4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low

Details 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low

1974-11-04

1976-01-20

Drezin, Norman A.

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

Polymer from ethylenic monomers only

424 78, 424330, A61K 31135

Patent

active

039339980

ABSTRACT:
Topical administration of 4-[2-(isopropylamino)ethyl]pyrocatechol to the mammalian eye reduces intraocular pressure without side effects generally associated with adrenergic activation such as tachycardia, mydriasis, hypertension and hypotension.

REFERENCES:
patent: 3849577 (1974-11-01), Holland
Luduena et al., Chemical Abstracts 64: 1188(f) (1966).
Luduena et al., Chemical Abstracts 64: 2591(a) (1966).
Weekers et al., Chemical Abstracts 66: 64226g (1967).
Fortenberry et al., Chemical Abstracts 71: 59474(b) (1969).
Leaders et al., Chemical Abstracts 74: 123505(d) (1971).
Podos et al., Chemical Abstracts 77: 14378(f) (1972).

Affiliated with

Also associated with

Rating

4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-[2-(Isopropylamino)ethyl]pyrocatechol intraocular pressure low will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1698632